Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-08

FDA Approved: DAPSONE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves the Original Application for DAPSONE from Rising Pharma Holdings, Inc., enabling a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

ORIG AP for DAPSONE (DAPSONE)